Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease.

Morten Asser KarsdalKate HallsworthJadine ScraggDiana J LeemingIda F VillesenLeah AveryLaura HaighOlivier GovaereSarah WichmannGuy TaylorSophie CassidyStuart McPhersonQuentin M Anstee

Published in: Hepatology communications (2023)

Thus, the likelihood of treatment response may be predicted at baseline by quantification of fibrogenesis biomarkers.

Keyphrases

weight loss
bariatric surgery
roux en y gastric bypass
single cell
gene expression
adipose tissue
metabolic syndrome
skeletal muscle
insulin resistance
weight gain
obese patients